The development of genome-wide association studies and their application to complex diseases,including lupus

Abstract

In this review, we explain the motivation for carrying out genome-wide association studies (GWAS), contrasting the achievements of linkage-based experiments for Mendelian traits with the difficulties found when applying that type of experiment to complex diseases. We explain the technical and organizational developments that were required to make GWAS feasible, as well as some of the theoretical concerns that were raised during the design of these studies.

We describe the impressive achievements of GWAS in lupus, and compare them with the experiences in three other genetically complex disorders: rheumatoid arthritis, type 1 diabetes and coronary heart disease. GWAS have been successful in identifying many new susceptibility loci for these four diseases, and have provided the motivation for novel immunological work.

We conclude by describing preliminary steps that have been taken towards translating the results of GWAS into improvements in patient care, explaining some of the difficulties involved, as well as successes that have already been achieved.

Keywords

Systemic lupus erythematosus cardiovascular disease renal lupus

Get full access to this article

View all access options for this article.

References

Visscher

Brown

McCarthy

Yang

. Five years of GWAS discovery. Am J Hum Genet 2012; 90: 7–24.

The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661–678.

Lessard

Ice

Adrianto

. The genomics of autoimmune disease in the era of genome-wide association studies and beyond. Autoimmun Rev 2012; 11: 267–275.

Guan

. Evaluation of coverage variation of SNP chips for genome-wide association studies. Eur J Hum Genet 2008; 16: 635–643.

The International Stroke Genetics Consortium and the Wellcome Trust Case Control Consortium 2. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 2012; 44: 328–333.

Weedon

Lango

Lindgren

. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008; 40: 575–583.

Moser

Kelly

Lessard

Harley

. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009; 10: 373–379.

The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s Disease chromosomes. Cell 1993; 72: 971–983.

Botstein

Risch

. Discovering genotypes underlying human phenotypes: Past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003; 33: 228–237.

10.

Risch

Merikangas

. The future of genetic studies of complex human diseases. Science 1996; 273: 1516–1517.

11.

Lander

. The new genomics: Global views of biology. Science 1996; 274: 536–539.

12.

Chakravarti

. Population genetics – making sense out of sequence. Nat Genet 1999; 21: 56–60.

13.

Reich

Lander

. On the allelic spectrum of human disease. Trends Genet 2001; 17: 502–510.

14.

Pritchard

. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001; 69: 124–137.

15.

Becker

. The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 2004; 62: 309–317.

16.

Hirschhorn

Daly

. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005; 6: 95–108.

17.

Wang

Barratt

Clayton

Todd

. Genome-wide association studies: Theoretical and practical concerns. Nat Rev Genet 2005; 6: 109–118.

18.

The International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437: 1299–1320.

19.

Storey

Tibshirani

. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003; 100: 9440–9445.

20.

Cordell

. Epistasis: What it means, what it doesn’t mean, and statistical methods to detect it in humans. Hum Mol Genet 2002; 11: 2463–2468.

21.

Todd

. Statistical false positive or true disease pathway? Nat Genet 2006; 38: 731–733.

22.

The International Consortium for Systemic Lupus Erythematosus Genetics. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204–210.

23.

Hom

Graham

Modrek

. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008; 358: 900–909.

24.

Graham

Cotsapas

Davies

. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008; 40: 1059–1061.

25.

Yang

Zhao

Hirankarn

. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai. Hum Mol Genet 2009; 18: 2063–2070.

26.

Han

Zheng

Cui

. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009; 41: 1234–1237.

27.

Gateva

Sandling

Hom

. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009; 41: 1228–1233.

28.

Adrianto

Wen

Templeton

. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet 2011; 43: 253–258.

29.

Cunninghame Graham

Morris

Bhangale

. Association of NCF2, IKZF1, IRF8, IFIH1 and TYK2 with systemic lupus erythematosus. PLoS Genet 2011; 7: e1002341–e1002341.

30.

Criswell

. The genetic contribution to systemic lupus erythematosus. Bull NYU Hosp Jt Dis 2008; 66: 176–183.

31.

Rhodes

Vyse

. The genetics of SLE: An update in the light of genome-wide association studies. Rheumatology 2008; 47: 1603–1611.

32.

Moser

Kelly

Lessard

Harley

. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009; 10: 373–379.

33.

Todd

Walker

Cooper

. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857–864.

34.

Hakonarson

Grant

Bradfield

. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007; 448: 591–595.

35.

Hakonarson

Bradfield

. A novel susceptibility locus for type 1 diabetes on chr12q13 identified by a genome-wide association study. Diabetes 2008; 57: 1143–1146.

36.

Cooper

Smyth

Smiles

. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 2008; 40: 1399–1401.

37.

Grant

SFA

Bradfield

. Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes 2009; 58: 290–295.

38.

Barrett

Clayton

Concannon

. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41: 703–707.

39.

Fung

Smyth

Howson

. Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus. Genes Immun 2009; 10: 188–191.

40.

Wallace

Smyth

Maisuria-Armer

. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet 2010; 42: 68–71.

41.

Bradfield

Wang

. A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet 2011; 7: e1002293–e1002293.

42.

Plenge

Seielstad

Padyukov

. TRAF1-C5 as a risk locus for rheumatoid arthritis – a genomewide study. N Engl J Med 2007; 357: 1199–1209.

43.

Plenge

Cotsapas

Davies

. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007; 39: 1477–1482.

44.

Raychaudhuri

Remmers

Lee

. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40: 1216–1223.

45.

Stahl

Raychaudhuri

Remmers

. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42: 508–514.

46.

Terao

Yamada

Ohmura

. The human AIRE gene at chromosome 21q22 is a genetic determinant for the predisposition to rheumatoid arthritis in Japanese population. Hum Mol Genet 2011; 20: 2680–2685.

47.

Freudenberg

Lee

Han

. Genome-wide association study of rheumatoid arthritis in Koreans: Population-specific as well as overlap with European susceptibility loci. Arthritis Rheum 2011; 63: 884–893.

48.

Samani

Erdmann

Hall

. Genomewide association analysis of coronary artery disease. N Engl J Med 2007; 357: 443–453.

49.

McPherson

Pertsemlidis

Kavaslar

. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316: 1488–1491.

50.

Erdmann

Großhenning

Braund

. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009; 41: 280–282.

51.

Trégouët

König

Erdmann

. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009; 41: 283–285.

52.

Ornish

Brown

Billings

. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129–133.

53.

Mehta

. A genome-wide association study in Europeans and South Asians identifies 5 new loci for coronary artery disease. Circ Cardiovasc Genet 2011; 4: 465–466.

54.

Lettre

Palmer

Young

. Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: The NHLBI CARe Project. PLoS Genet 2011; 7: e1001300–e1001300.

55.

Schunkert

König

Kathiresan

. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 43: 333–338.

56.

The Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2011; 43: 339–344.

57.

Wang

. Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet 2011; 43: 345–349.

58.

Slavin

Feng

Schnell

. Two-marker association tests yield new disease associations for coronary artery disease and hypertension. Hum Genet 2011; 130: 725–733.

59.

Wild

Zeller

Schillert

. A genome-wide study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet 2011; 4: 403–412.

60.

Barbalic

Reiner

. Genome-wide association analysis of incident coronary heart disease (CHD) in African Americans: A short report. PLoS Genet 2011; 7: e1002199–e1002199.

61.

Takeuchi

Yokota

Yamamoto

. Genome-wide association study of coronary artery disease in the Japanese. Eur J Hum Genet 2012; 20: 333–340.

62.

Hasnain

Banerjee

Ehtesham

. Translating advances in genomic research into clinical practice: The challenges ahead. Med Princ Pract 2011; 20: 392–394.

63.

Blumberg

Dittel

Hafler

von Herrath

Nestle

. Unraveling the autoimmune translational research process layer by layer. Nat Med 2012; 18: 35–41.

64.

Couzin-Frankel

. Trying to reset the clock on type 1 diabetes. Science 2011; 333: 819–821.

65.

Navarra

Guzmán

Gallacher

. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: A randomised, placebo-controlled, phase 3 trial. Lancet 2011; 377: 721–731.